Skip to main content
. 2021 Nov 23;12:789914. doi: 10.3389/fimmu.2021.789914

Figure 6.

Figure 6

m6A modification patterns and clinical relevance. (A) The proportion of patients surviving between the low and high m6A score groups, with a higher proportion surviving in the high scoring group (35% survival in the low m6A score group and 62% survival in the high m6A score groups). (B) m6A scores were higher in surviving patients than in patients who died. (C–F) Different gene expressions among low and high m6A score groups.